AR122491A1 - Agente preventivo de adhesión y método preventivo de adhesión usando el mismo - Google Patents

Agente preventivo de adhesión y método preventivo de adhesión usando el mismo

Info

Publication number
AR122491A1
AR122491A1 ARP210101482A ARP210101482A AR122491A1 AR 122491 A1 AR122491 A1 AR 122491A1 AR P210101482 A ARP210101482 A AR P210101482A AR P210101482 A ARP210101482 A AR P210101482A AR 122491 A1 AR122491 A1 AR 122491A1
Authority
AR
Argentina
Prior art keywords
adhesion preventive
same
agent
adhesion prevention
adhesion
Prior art date
Application number
ARP210101482A
Other languages
English (en)
Spanish (es)
Inventor
Atsushi OHHATA
Hiromichi Yamashita
Shiori Fujimoto
Original Assignee
Otsuka Pharma Factory Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Otsuka Pharma Factory Inc filed Critical Otsuka Pharma Factory Inc
Publication of AR122491A1 publication Critical patent/AR122491A1/es

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/70—Carbohydrates; Sugars; Derivatives thereof
    • A61K31/715—Polysaccharides, i.e. having more than five saccharide radicals attached to each other by glycosidic linkages; Derivatives thereof, e.g. ethers, esters
    • A61K31/716—Glucans
    • A61K31/722—Chitin, chitosan
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
    • A61L31/00—Materials for other surgical articles, e.g. stents, stent-grafts, shunts, surgical drapes, guide wires, materials for adhesion prevention, occluding devices, surgical gloves, tissue fixation devices
    • A61L31/04—Macromolecular materials
    • A61L31/042—Polysaccharides
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/70—Carbohydrates; Sugars; Derivatives thereof
    • A61K31/715—Polysaccharides, i.e. having more than five saccharide radicals attached to each other by glycosidic linkages; Derivatives thereof, e.g. ethers, esters
    • A61K31/716—Glucans
    • A61K31/717—Celluloses
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/08—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing oxygen, e.g. ethers, acetals, ketones, quinones, aldehydes, peroxides
    • A61K47/10—Alcohols; Phenols; Salts thereof, e.g. glycerol; Polyethylene glycols [PEG]; Poloxamers; PEG/POE alkyl ethers
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/30—Macromolecular organic or inorganic compounds, e.g. inorganic polyphosphates
    • A61K47/36—Polysaccharides; Derivatives thereof, e.g. gums, starch, alginate, dextrin, hyaluronic acid, chitosan, inulin, agar or pectin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/30—Macromolecular organic or inorganic compounds, e.g. inorganic polyphosphates
    • A61K47/36—Polysaccharides; Derivatives thereof, e.g. gums, starch, alginate, dextrin, hyaluronic acid, chitosan, inulin, agar or pectin
    • A61K47/38—Cellulose; Derivatives thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00—Cosmetics or similar toiletry preparations
    • A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/72—Cosmetics or similar toiletry preparations characterised by the composition containing organic macromolecular compounds
    • A61K8/73—Polysaccharides
    • A61K8/731—Cellulose; Quaternized cellulose derivatives
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/70—Web, sheet or filament bases ; Films; Fibres of the matrix type containing drug
    • A61K9/7007—Drug-containing films, membranes or sheets
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
    • A61L31/00—Materials for other surgical articles, e.g. stents, stent-grafts, shunts, surgical drapes, guide wires, materials for adhesion prevention, occluding devices, surgical gloves, tissue fixation devices
    • A61L31/12—Composite materials, i.e. containing one material dispersed in a matrix of the same or different material
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
    • A61L31/00—Materials for other surgical articles, e.g. stents, stent-grafts, shunts, surgical drapes, guide wires, materials for adhesion prevention, occluding devices, surgical gloves, tissue fixation devices
    • A61L31/14—Materials characterised by their function or physical properties, e.g. injectable or lubricating compositions, shape-memory materials, surface modified materials
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
    • A61L2400/00—Materials characterised by their function or physical properties
    • A61L2400/12—Nanosized materials, e.g. nanofibres, nanoparticles, nanowires, nanotubes; Nanostructured surfaces

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Chemical & Material Sciences (AREA)
  • Epidemiology (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Engineering & Computer Science (AREA)
  • Vascular Medicine (AREA)
  • Surgery (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Inorganic Chemistry (AREA)
  • Molecular Biology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Materials Engineering (AREA)
  • Composite Materials (AREA)
  • Organic Chemistry (AREA)
  • Oil, Petroleum & Natural Gas (AREA)
  • Birds (AREA)
  • Materials For Medical Uses (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Sealing Material Composition (AREA)
  • Paints Or Removers (AREA)
  • Adhesives Or Adhesive Processes (AREA)
  • Treatments For Attaching Organic Compounds To Fibrous Goods (AREA)
ARP210101482A 2020-06-01 2021-06-01 Agente preventivo de adhesión y método preventivo de adhesión usando el mismo AR122491A1 (es)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
JP2020095280 2020-06-01

Publications (1)

Publication Number Publication Date
AR122491A1 true AR122491A1 (es) 2022-09-14

Family

ID=78831085

Family Applications (1)

Application Number Title Priority Date Filing Date
ARP210101482A AR122491A1 (es) 2020-06-01 2021-06-01 Agente preventivo de adhesión y método preventivo de adhesión usando el mismo

Country Status (13)

Country Link
US (1) US20230226098A1 (https=)
EP (1) EP4159251A4 (https=)
JP (2) JP7321610B2 (https=)
KR (1) KR20230018490A (https=)
CN (1) CN115884800A (https=)
AR (1) AR122491A1 (https=)
AU (1) AU2021284433A1 (https=)
BR (1) BR112022022193A2 (https=)
CA (1) CA3189526A1 (https=)
MX (1) MX2022015193A (https=)
TW (1) TW202210113A (https=)
WO (1) WO2021246388A1 (https=)
ZA (1) ZA202211627B (https=)

Families Citing this family (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP7832428B2 (ja) * 2021-02-26 2026-03-18 国立大学法人信州大学 表面修飾多糖類ナノ材料、その分散液、機能性物品及び機能性物品の加工法
CN114904053A (zh) * 2022-05-31 2022-08-16 重庆大学 一种基于纤维素纳米晶的抗炎防组织粘连生物涂层及其制备方法和应用
DE102023116601A1 (de) 2022-06-29 2024-01-04 Semiconductor Energy Laboratory Co., Ltd. Licht emittierende Vorrichtung

Family Cites Families (21)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6610669B1 (en) * 1987-09-18 2003-08-26 Genzyme Corporation Water insoluble derivatives of polyanionic polysaccharides
DE69015775T2 (de) * 1989-10-31 1995-05-11 Howmedica Chitinderivate enthaltende Zusammensetzungen zur Verhütung der Adhäsion.
JP3545790B2 (ja) 1993-09-30 2004-07-21 味の素ファルマ株式会社 腹腔内の癒着防止剤
WO2005000374A1 (ja) * 2003-06-30 2005-01-06 Denki Kagaku Kogyo Kabushiki Kaisha 脊椎・脊髄手術用癒着防止材
JP4998981B2 (ja) 2006-06-20 2012-08-15 国立大学法人 東京大学 微細セルロース繊維
JP5001246B2 (ja) 2008-09-26 2012-08-15 古河電池株式会社 蓄電池用モノブロック電槽
RU2012146357A (ru) * 2010-03-31 2014-05-10 Хоги Медикал Ко., Лтд. Предотвращающий адгезию материал
WO2013047218A1 (ja) * 2011-09-30 2013-04-04 日本製紙株式会社 セルロースナノファイバーの製造方法
JP6199858B2 (ja) * 2012-03-14 2017-09-20 日本製紙株式会社 アニオン変性セルロースナノファイバー分散液の製造方法
JP5921960B2 (ja) 2012-06-04 2016-05-24 第一工業製薬株式会社 無機微粒子含有組成物およびそれを用いた被膜
EP2998435B1 (en) 2013-05-16 2021-10-13 Oji Holdings Corporation Phosphoric acid esterified cellulose fibers and production method thereof
JP2015099083A (ja) 2013-11-19 2015-05-28 三菱重工業株式会社 酸露点腐食評価装置及び酸露点腐食評価方法
WO2015099083A1 (ja) * 2013-12-25 2015-07-02 日産化学工業株式会社 血清および血液を固化する水分散液
JP2017155024A (ja) 2016-03-04 2017-09-07 株式会社ユーグレナ 細胞増殖促進剤
KR102232614B1 (ko) 2016-07-21 2021-03-29 난징 산홈 팔마세우티칼 컴퍼니 리미티드 이소시트레이트 탈수소효소 억제제의 화학적 화합물 및 이의 적용
CA3049855C (en) 2017-01-16 2022-06-14 Kri, Inc. Sulfuric acid esterification modified cellulose nanofibers and method for producing cellulose nanofibers
JP6958799B2 (ja) * 2017-05-25 2021-11-02 日本製紙株式会社 ハイドロゲル
CN110520448B (zh) 2017-06-16 2023-04-07 东亚合成株式会社 纤维素纳米纤维的制造方法
KR102031178B1 (ko) * 2017-07-14 2019-10-11 순천향대학교 산학협력단 주입형 온도감응성 목재 기반 산화 나노 셀룰로오스를 포함한 유착 방지제
SI3533458T1 (sl) * 2018-03-02 2023-09-29 Upm-Kymmene Corporation Medicinski izdelek, ki vsebuje bioaktivno molekulo, ki je imobilizirana na nanofibrilarno celulozo in postopek za njegovo pripravo
CN109966540B (zh) * 2019-04-04 2020-06-23 武汉大学 一种纳米甲壳素复合海藻酸钙医用敷料的制备方法及应用

Also Published As

Publication number Publication date
KR20230018490A (ko) 2023-02-07
JP7321610B2 (ja) 2023-08-07
EP4159251A4 (en) 2024-06-19
US20230226098A1 (en) 2023-07-20
TW202210113A (zh) 2022-03-16
JPWO2021246388A1 (https=) 2021-12-09
MX2022015193A (es) 2023-01-04
EP4159251A1 (en) 2023-04-05
BR112022022193A2 (pt) 2022-12-13
CA3189526A1 (en) 2021-12-09
JP2023096193A (ja) 2023-07-06
AU2021284433A1 (en) 2022-12-01
WO2021246388A1 (ja) 2021-12-09
ZA202211627B (en) 2024-02-28
CN115884800A (zh) 2023-03-31

Similar Documents

Publication Publication Date Title
AR122491A1 (es) Agente preventivo de adhesión y método preventivo de adhesión usando el mismo
CL2023003068A1 (es) Compuestos, composiciones y métodos para el tratamiento de trastornos
UY38476A (es) Inhibidores de arg1 y/o arg2
AR115760A1 (es) Composición y película de polietileno con buena permeabilidad, rigidez y sellabilidad
AR115765A1 (es) Composición y película de polietileno de alta rigidez, sellabilidad sobresaliente y alta permeabilidad
CL2021002669A1 (es) (divisional de solicitud 3443-2018) tratamientos de cancer.
AR062212A1 (es) Composicion y metodo en relacion con la prevencion y la solucion del dano del gel surfactante
AR067563A1 (es) Polimeros funcionalizados, articulos preparaddos de los mismos, y sus metodos de eleboracion
CL2019003892A1 (es) Nuevos derivados de azaquinolina.
PH12023500023A1 (en) Cdk2 degraders and uses thereof
BR112021021921A2 (pt) Agente, uso de um agente e método de tratamento ou prevenção de uma doença metabólica
CY1118655T1 (el) Χρηση 2,4-πυριμιδινοδιαμινων για τη θεραπεια της αθηροσκληρωσης
AR032663A1 (es) Composicion de revestimiento mejorada
BR112019024264A2 (pt) Antimitoscinas: inibidores direcionados da biogênese mitoconcrial para erradicação de células-tronco de câncer
CO2021002691A2 (es) Composiciones y métodos para editar el gen hidroxiácido oxidasa 1 (hao1) para tratar la hiperoxaluria primaria tipo 1 (ph1)
BR112018071602A2 (pt) compostos de imidazopiridina substituídos como inibidores da indolamina 2,3-dioxigenase e/ou triptofano-2,3-dioxigenase
CO2022000481A2 (es) Inhibidores de enzimas
CL2025000822A1 (es) Inhibidores de pcsk9 y métodos de uso de los mismos.
MX2025006791A (es) Agente de iarn con nucleótidos modificados
BR112022008504A2 (pt) Composição de sabão
WO2018144460A8 (en) Topcoat for permanent lip make up
MX2021010152A (es) Moduladores de la expresion de malat1.
CL2023001965A1 (es) Ácido ribonucleico bicatenario capaz de suprimir la expresión de c5 de complemento (divisional).
AR129796A1 (es) Composiciones de tirzepatida y uso
CO2025018165A2 (es) Agonistas de trem2

Legal Events

Date Code Title Description
FG Grant, registration